As of January 22, 2025, Banque Cantonale Vaudoise (BCVN.SW) has a market cap of $8.44 billion USD. According to our data, Banque Cantonale Vaudoise is ranked No.1884 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $8.44 B |
6.65%
|
Dec 30, 2024 | $7.92 B |
-19.58%
|
Dec 29, 2023 | $9.84 B |
27.60%
|
Dec 30, 2022 | $7.71 B |
31.22%
|
Dec 30, 2021 | $5.88 B |
-23.52%
|
Dec 30, 2020 | $7.69 B |
27.36%
|
Dec 30, 2019 | $6.04 B |
11.56%
|
Dec 28, 2018 | $5.41 B |
5.07%
|
Dec 29, 2017 | $5.15 B |
15.56%
|
Dec 30, 2016 | $4.46 B |
2.83%
|
Dec 30, 2015 | $4.33 B |
20.19%
|
Dec 30, 2014 | $3.61 B |
12.96%
|
Dec 30, 2013 | $3.19 B |
2.20%
|
Dec 28, 2012 | $3.12 B |
8.41%
|
Dec 30, 2011 | $2.88 B |
-5.32%
|
Dec 30, 2010 | $3.04 B |
23.01%
|
Dec 31, 2009 | $2.47 B |
36.14%
|
Dec 31, 2008 | $1.82 B |
-34.36%
|
Dec 31, 2007 | $2.77 B |
-13.68%
|
Dec 29, 2006 | $3.21 B |
56.88%
|
Dec 30, 2005 | $2.04 B |
86.84%
|
Dec 31, 2004 | $1.09 B |
46.79%
|
Dec 31, 2003 | $0.75 B |
76.25%
|
Dec 31, 2002 | $0.42 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
BioNTech
BNTX
|
$27.52 B |
-0.001 M
|
Germany
|
Moderna
MRNA
|
$14.88 B |
0.000 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$75.23 B |
1.245 B
|
USA
|
Gilead Sciences
GILD
|
$116.07 B |
0.004 M
|
USA
|
Pfizer
PFE
|
$148.34 B |
-0.006 M
|
USA
|
Johnson & Johnson
JNJ
|
$347.78 B |
-0.005 M
|
USA
|
AstraZeneca
AZN
|
$211.43 B |
0.005 M
|
UK
|
Merck
MRK
|
$242.59 B |
0.007 M
|
USA
|
Sanofi
SNY
|
$128.55 B |
0.003 M
|
France
|
Eli Lilly
LLY
|
$676.92 B |
0.020 M
|
USA
|
Novavax
NVAX
|
$1.42 B |
-0.000 M
|
USA
|
GlaxoSmithKline
GSK
|
$68.38 B |
0.002 M
|
UK
|
AbbVie
ABBV
|
$300.53 B |
0.002 M
|
USA
|
Amgen
AMGN
|
$147.53 B |
0.002 M
|
USA
|
Market Cap | = | BCVN.SW Stock Price | * | BCVN.SW Shares Outstanding |
= | $98.30 | * | 85.89 M | |
= | $8.44 B |